Seaweed compound could ease arthritis pain in new trial
NCT ID NCT07045896
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether fucoidan, a substance from brown seaweed, can help adults with active rheumatoid arthritis who haven't improved enough on standard medications. The trial will enroll 40 people and follow them for 12 weeks to see if joint pain and swelling improve. Fucoidan works by blocking a specific immune target (SR-A) that is overactive in rheumatoid arthritis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell study could pave way for new arthritis treatments
- Are women with autoimmune diseases getting the gynecological care they need?
- Brain scans may predict who gets long-term pain from arthritis
- Can mindfulness ease arthritis pain? small study seeks answers
- Can a simple blood test help rheumatoid arthritis patients get the right drug?
- Tiny study peers inside finger joints to unlock RA bone erosion secrets